Article Text

Download PDFPDF

B57 Postoperative pain management after total knee arthroplasty: LIA vs. FNB+DIB using a ropivacaine-dexmedetomidine combination
Free
  1. K Kovalevska,
  2. A Sandner-Kiesling,
  3. M Rief,
  4. P Reinbacher and
  5. GA Schittek
  1. Medical University of Graz, Graz, Austria

Abstract

Background and Aims Postoperative pain management after total knee arthroplasty (TKA) remains a major challenge. Ultrasound-guided regional anesthesia (UGRA) using femoral nerve block (FNB) and distal ischiadicus block (DIB) is a standard procedure for primary TKA. Local infiltration analgesia (LIA) is an alternate approach that applies the concept of surgical wound infiltration with local anaesthetics, which gained widespread popularity because of ease of application, cost effectiveness and lack of apparent motor block.

The aim of our RCT was to evaluate LIA vs. UGRA concepts in TKA when dexmedetomidine is used as an adjuvant. Working hypothesis: periarticular LIA would have disadvantages over UGRA in terms of postoperative pain control.

Methods 50 Patients received LIA of the knee capsule during surgery with 60 ml ropivacaine 0.5% and 1 ml (100 mcg) dexmedetomidine or two single-shot USRA blocks (NFB and DIB) before surgery with 15 ml each of ropivacaine 0.5% and 0.5 ml each (50 mcg) dexmedetomidine. (Ethical Committee No. 32–239 ex 19/20, 16.12.2020).

Results The safety analysis showed significantly higher need for opioids in the LIA group with a median oral morphine equivalent of 42.0 [IQR 23.5 to 57.0] mg vs. 27.0 [IQR 0.0 to 33.6] mg (P=0.022).

Abstract B57 Table 1

Baseline characteristics

Abstract B57 Table 2

Opioid consumption

Conclusions Our study demonstrated a superior opioid-sparing effect of UGRA compared with LIA when dexmedetomidine was added. We observed a longer-lasting opioid-sparing effect compared with recently published literature, which may be due to the addition of dexmedetomidine. Multimodal analgesia concepts could be improved when LIA or UGRA techniques are combined with dexmedetomidine.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.